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Background
Recent years immunotherapy has been used to treat var-
ious diseases especially cancer. The dendritic cell therapy
has been one of the most widely practiced therapies in
clinics and usually monocytes are isolated as the source of
dendritic cells. However, although dendritic cell therapy
shows its effect in cancer treatment, a big problem is one
cannot guarantee an enough number of cells for treat-
ment. This is mainly due to the inefficiency of monocyte
isolation.
Methods
Up to now, various methods for selectively isolating
monocytes have been developed to trap as many mono-
cytes as possible. For example, a method using a density-
gradient centrifugation and a method using magnetic
beads with antibodies affinitive to cells have been pro-
moted for several years. However, these methods show
rare possibilities to instead the plastic adherence which is
the most commonly used method for monocyte isolation.
The first reason is proposed to be the complicated operat-
ing process. The second reason might be their low cost
performance.
Results
Here we present a new material that gives a high affinity
to monocytes but other PBMCs. Plastic dishes or glass
dishes coated with this material were used to attract
monocytes using a protocol exactly the same with the
traditional plastic adherence protocol. The differentia-
tion of monocytes to dendritic cells were carried out by
adding GM-CSF and IL-4 to the culture medium and
the maturation of those dendritic cells was proceeded by
addition of TNF alpha and PGE2.
Conclusions
As the results indicated, we gained more adhered mono-
cytes comparing with the traditional plastic adherence.
Therefore, we believe that this material will be widely used
in monocyte isolation and hence contribute to dendritic
cell therapy.
Authors’ details
1Medical Device Development Laboratories, Kaneka Corp., Takasago, Japan.
2University of Kyushu, Japan, Fukuoka, Japan.
Published: 4 November 2015
doi:10.1186/2051-1426-3-S2-P212
Cite this article as: Zhang et al.: Efficient isolation of monocytes from
PBMCs utilizing a newly developed material. Journal for ImmunoTherapy
of Cancer 2015 3(Suppl 2):P212.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit1Medical Device Development Laboratories, Kaneka Corp., Takasago, Japan
Full list of author information is available at the end of the article
Zhang et al. Journal for ImmunoTherapy of Cancer 2015, 3(Suppl 2):P212
http://www.immunotherapyofcancer.org/content/3/S2/P212
© 2015 Zhang et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
